When scientists first discovered CRISPR, the possibilities for gene editing seemed endless. But challenges remain when it comes to actually translating that discovery into a therapy that works for ...
The CRISPR entry notes both its original function, as an immune defense in bacteria and archaea, and its recent adoption as a gene editing tool. The latter part of the definition raised eyebrows for ...
CRISPR Therapeutics had its first FDA-approved product in December 2023, a treatment for sickle cell disease called Casgevy. It’s also developing treatments for cancer and cardiovascular disease using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results